Researchers believe that they have found a way to
help those with celiac disease.
A study conducted in the Gastroenterology journal
found that the gluten-specific enzyme ALV003 reduced a patient’s exposure to
gluten better than a placebo.
While most people don’t seem to know what gluten
really is , you’ve probably seen it linked to Celiac Disease, a digestive
disease that damages the intestine when consuming gluten.
Researchers hope the ALV003 enzyme can lead to a
pill that aids gluten-intolerant folks. Even with a gluten-free diet, there is
still potential harm being done to the intestines through accidental gluten
consumption. Theoretically, the pill would reduce the harm done by the sneaky
protein composite.
In the study, researchers randomly selected 41
people in Finland diagnosed with celiac disease to take either ALV003 or a
placebo pill every day. They then asked them to eat 2 grams of gluten daily for
6 weeks and took samples of the small intestine to analyze. Daniel Adelman, the
lead researcher found that the those who took the placebo pill had a notably
higher amount of intestinal injuries and inflammation than those who took the
ALV003 pill. There a was no visible change in the intestines of the subjects
who took ALV003, suggesting the pill protected them from harm.
By: Isai
Rocha
No comments:
Post a Comment